STUDY ON THE VASCULAR EFFECTS OF CHRONIC ADMINISTRATION OF TWO SULFONYLUREAS, CHLORPROPAMIDE AND GLIBENCLAMIDE, ON THE HEALTHY RAT THORACIC AORTA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAFEI M.; HOMAYOUN FAR HOMAYOUN; IZADPANAH E.; MAHMOUDIAN M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Razi Journal of Medical Sciences Year:2003 | Volume:10 | Issue:38 (SPECIAL ISSUE) Page(s): 885-894

Download Full-Text

Persian Verion

View:

1,744

Download:

Cites:

Information Journal Paper

Title

STUDY ON THE VASCULAR EFFECTS OF CHRONIC ADMINISTRATION OF TWO SULFONYLUREAS, CHLORPROPAMIDE AND GLIBENCLAMIDE, ON THE HEALTHY RAT THORACIC AORTA

Author(s)

SHAFEI M. | HOMAYOUN FAR HOMAYOUN | IZADPANAH E. | MAHMOUDIAN M. | Issue Writer Certificate

Keywords

SULFONYLUREAS - GLIBENCLAMIDE - CHLORPROPAMIDE - RAT AORTAQ3

Abstract

Diabetes mellitus is one of the most common endocrine disorders with increasing prevalence. Cardiovascular complications are among the major causes of death in diabetic patients. Type II diabetes mellitus is generally treated with sulfonylureas. There are controversial reports regarding adverse cardiovascular effects of these drugs. Also evidence exists about differences in side effects between first and second generation sulfonylureas. Thus, an experimental and prospective study was performed. In this study, the vascular effects of two sulfonylureas belonging to the first(chlorpropamide) and second generation(glibenclamide) were investigated in healthy male rats. Healthy rats were treated with chlorpropamide(8mg/kg/day; i.p.) and glibenclamide(0.285mg/kg/day; i.p.) for oneand two-month periods and the response of isolated aortic rings to phenylephrine, acetylcholine and isosorbide dinitrate were then examined and compared to control. The results showed that chlopropamide pretreatment after two months caused a significant reduction in contractile response to phenylephrine. Moreover, a significant increase in endothelium-dependent relaxation in response to ACh was also observed after a two-month period of pretreatment with chlorpropamide. Such changes were not observed after one month administration so it appears that these changes are time dependent. Glibenclamide did not cause such changes after one-or two-month pretreatment. Calculated EC50s for either phenylephrine or ACh did not differ in test groups compared to control. So it is suggested that changes in the characteristics of smooth muscle alpha-1 adrenoceptors or endothelial muscarinic receptors may not be involved in the observed responses. The alpha-1 adrenoceptor-induced vasocontriction appears to be caused both by the release of intracellular Ca2+ and by the transmembranous influx of extracellular Ca2+ It has been demonstrated that glibenclamide may interfere with Ca2+ influx which in turn affects intracellular Ca2+ levels in arterial smooth muscle, leading to reduction to muscle contractility. Inhibitory effect of glibenclamide in the protein kinase-C mediated contractile mechanism has also been suggested. The observed effect of chlorpropamide on phenylephrine-induced contraction can be attributed to such mechanisms and a longer pretreatment may be needed for glibenclamide to show its inhibitory effect on contractile response to phenylephrine. On the other hand, it has been shown that sulfonylureas may stimulate the proliferation of endothelial cells from large vessels. There may be a difference between chlorpropamide and glibenclamide in the time needed to cause such an effect. Also, it is possible that vascular effects of chlorpropamide are due, at least in part, to changes in the post-receptor cellular components which are involved in signal transduction. Results obtained in this study indicate that up to two months pretreatment with chlorpropamide and glibenclamide in healthy rats did not affect the aortic function in such a way to contribute to hypertension.

Cites

No record.

References

No record.

Cite

APA: Copy

SHAFEI, M., HOMAYOUN FAR, HOMAYOUN, IZADPANAH, E., & MAHMOUDIAN, M.. (2003). STUDY ON THE VASCULAR EFFECTS OF CHRONIC ADMINISTRATION OF TWO SULFONYLUREAS, CHLORPROPAMIDE AND GLIBENCLAMIDE, ON THE HEALTHY RAT THORACIC AORTA. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), 10(38 (SPECIAL ISSUE)), 885-894. SID. https://sid.ir/paper/10800/en

Vancouver: Copy

SHAFEI M., HOMAYOUN FAR HOMAYOUN, IZADPANAH E., MAHMOUDIAN M.. STUDY ON THE VASCULAR EFFECTS OF CHRONIC ADMINISTRATION OF TWO SULFONYLUREAS, CHLORPROPAMIDE AND GLIBENCLAMIDE, ON THE HEALTHY RAT THORACIC AORTA. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES)[Internet]. 2003;10(38 (SPECIAL ISSUE)):885-894. Available from: https://sid.ir/paper/10800/en

IEEE: Copy

M. SHAFEI, HOMAYOUN HOMAYOUN FAR, E. IZADPANAH, and M. MAHMOUDIAN, “STUDY ON THE VASCULAR EFFECTS OF CHRONIC ADMINISTRATION OF TWO SULFONYLUREAS, CHLORPROPAMIDE AND GLIBENCLAMIDE, ON THE HEALTHY RAT THORACIC AORTA,” RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), vol. 10, no. 38 (SPECIAL ISSUE), pp. 885–894, 2003, [Online]. Available: https://sid.ir/paper/10800/en

Related Journal Papers